Midazolam increases cisplatin-sensitivity in non-small cell lung cancer (NSCLC) via the miR-194-5p/HOOK3 axis

As previously reported, midazolam anesthesia exerts tumor-suppressing effects in non-small cell lung cancer (NSCLC), but the regulating effects of this drug on cisplatin-resistance in NSCLC have not been studi...

Source: Cancer Cell International - July 28, 2021 Category: Cancer & Oncology Authors: Tingting Sun, Jing Chen, Xuechao Sun and Guonian Wang Tags: Primary research Source Type: research